Stage IIA Pancreatic Cancer AJCC v8

14 clinical trials · Condition

Record	Firm	Date
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer (NCT04821284)	Flemming Forsberg	2021-12-06
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer (NCT04940286)	M.D. Anderson Cancer Center	2021-09-28
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer (NCT05055323)	Thomas Jefferson University	2021-07-29
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer (NCT04887805)	City of Hope Medical Center	2021-07-21
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172)	Thomas Jefferson University	2020-11-10
Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas (NCT03925428)	National Cancer Institute (NCI)	2020-09-18
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer (NCT04106856)	University of Utah	2019-08-08
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer (NCT03432676)	M.D. Anderson Cancer Center	2019-07-31
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors (NCT03784677)	M.D. Anderson Cancer Center	2019-07-29
IACS-010759 in Advanced Cancers (NCT03291938)	M.D. Anderson Cancer Center	2017-11-13

Every clearance here is in the API, with alerts when new ones post.